Low Frequency of VEGF/VEGFR Inhibitor
associated Adverse Events (Adenocarcinoma)
Reck M, et al. J Clin Oncol 32:5s, 2014 (suppl; abstr 8100 and poster);
ATE = arterial thromboembolism; GI = gastrointestinal; VEGF = vascular endothelial growth factor; VEGFR = vascular endothelial growth factor receptor;
VTE = venous thromboembolism
All grades (%)
Patients (%)
Nintedanib + docetaxel
Placebo + docetaxel
Nintedanib + docetaxel
Placebo + docetaxel
Grade ≥3 (%)
